OTC News & Analysis
2 articles
Market Mood
Enflame (OTC) Soars 206% on IPO Amid AI Demand
Chinese chipmaker Enflame (OTC) saw its stock surge 206% on its debut in Shanghai, driven by strong demand with over 6,000 times the shares ordered during its initial retail offering. Enflame is developing domestic alternatives to U.S. rivals like Nvidia, which held nearly 60% of China's AI accelerator market in 2025. The company reported revenue of 990 million yuan ($147 million) in 2025, an increase from 722 million yuan the previous year. For investors, this marks a significant opportunity as China's semiconductor sector continues to grow amid efforts for tech self-sufficiency.
Read More: Enflame (OTC) Soars 206% on IPO Amid AI Demand
Quantum Helium (QHELI) Q1 Oil Output and US OTC Listing Plans
Quantum Helium (QHELI) reported its Q1 oil output figures, showing a production level of 10,000 barrels. The company is also exploring the possibility of listing on the US OTC market to enhance visibility and accessibility to investors. This move could potentially attract more investors and increase trading volume for QHELI shares. The decision to pursue an OTC listing reflects a strategy to broaden its market presence and engagement with a wider audience.
Read More: Quantum Helium (QHELI) Q1 Oil Output and US OTC Listing Plans